BIOAF

Bioasis Technologies Inc.

OTC Markets OTCPKUSDEQUITY DELAYED

0.00

■ 0.00 (0.00%)

MARKET · —

Price

Open

—

Prev close

0.00

Day high

0.00

Day low

0.00

Volume

72.94K

Market cap

—

P/E (TTM)

—

52W range

0.00 – 0.00

Options chain

Account required

ExpirySpot 0.00

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Trailing performance

Price return · vs SPY

Returnvs SPY

0.00% +1.4%

0.00% -3.7%

0.00% -3.1%

-50.00% -61.1%

YTD

-50.00% -62.3%

-50.00% -70.0%

-98.33% -172.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Financial statements

As reported · 1 year

Blank means not reported, not zero

Line item	2022	YoY
Total revenue	$37.73K
Operating revenue	$37.73K
Research & development	$1.23M
Selling, general & admin	$2.41M
Total operating expense	$3.63M
Operating income	-$3.60M
Net interest income	-$654.21K
Pre-tax income	-$2.96M
Net income	-$2.96M
Net income to common	-$2.96M
Basic EPS	-0.04
Diluted EPS	-0.04
EBIT	-$3.60M
EBITDA	-$3.54M
Basic shares	72.17M
Diluted shares	72.17M

Line item

2022

YoY

Total revenue

$37.73K

Operating revenue

$37.73K

Research & development

$1.23M

Selling, general & admin

$2.41M

Total operating expense

$3.63M

Operating income

-$3.60M

Net interest income

-$654.21K

Pre-tax income

-$2.96M

Net income

-$2.96M

Net income to common

-$2.96M

Basic EPS

-0.04

Diluted EPS

-0.04

EBIT

-$3.60M

EBITDA

-$3.54M

Basic shares

72.17M

Diluted shares

72.17M

Line item	2022	YoY
Cash & equivalents	$1.73M
Cash & short-term investments	$1.73M
Accounts receivable	$97.67K
Total current assets	$2.11M
Property, plant & equipment	$216
Goodwill & intangibles	$158.96K
Total assets	$2.27M
Total current liabilities	$2.99M
Current debt	$1.50M
Long-term debt	$401.76K
Total debt	$1.90M
Total liabilities	$4.18M
Retained earnings	-$40.65M
Shareholder equity	-$1.92M
Working capital	-$882.74K
Net tangible assets	-$2.08M
Shares issued	72.91M

Line item

2022

YoY

Cash & equivalents

$1.73M

Cash & short-term investments

$1.73M

Accounts receivable

$97.67K

Total current assets

$2.11M

Property, plant & equipment

$216

Goodwill & intangibles

$158.96K

Total assets

$2.27M

Total current liabilities

$2.99M

Current debt

$1.50M

Long-term debt

$401.76K

Total debt

$1.90M

Total liabilities

$4.18M

Retained earnings

-$40.65M

Shareholder equity

-$1.92M

Working capital

-$882.74K

Net tangible assets

-$2.08M

Shares issued

72.91M

Line item	2022	YoY
Net income	-$2.96M
Depreciation & amortisation	$54.92K
Stock-based compensation	$440.58K
Change in working capital	-$401.70K
Operating cash flow	-$3.64M
Investing cash flow	$0
Financing cash flow	$2.64M
Free cash flow	-$3.64M
End cash position	$1.73M

Line item

2022

YoY

Net income

-$2.96M

Depreciation & amortisation

$54.92K

Stock-based compensation

$440.58K

Change in working capital

-$401.70K

Operating cash flow

-$3.64M

Investing cash flow

Financing cash flow

$2.64M

Free cash flow

-$3.64M

End cash position

$1.73M

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.00

+0.00% from price

SMA 20

0.00

0.00% from price

SMA 50

0.00

0.00% from price

SMA 100

0.00

-7.41% from price

SMA 200

0.00

-35.06% from price

EMA 12

0.00

-0.00% from price

EMA 26

0.00

-0.08% from price

EMA 50

0.00

-2.46% from price

RSI (14)

0.0

Oversold

MACD (12,26,9)

-0.00

Hist 0.00

ATR (14)

0.00

—

Realised vol 30D

0.0%

Annualised

Bollinger upper

0.00

20, 2σ

Bollinger lower

0.00

20, 2σ

50 / 200 cross

Death

0.00 vs 0.00

Trend bias

Below 200

-35.06%

Risk profile

Daily returns · 1Y window

Beta vs SPY

-0.27

Less volatile than market

Correlation to SPY

-0.07

Largely independent

Realised vol 30D

0.0%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-50.0%

Peak to trough

Max drawdown 5Y

-100.0%

Peak to trough

ATR 14

0.00

Average true range

Beta (reported)

—

5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.